Image

Global Implantable Drug Delivery Market – Industry Trends and Forecast to 2029

  • Healthcare
  • Upcoming Report
  • Dec 2021
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60
  • Healthcare
  • Upcoming Report
  • Dec 2021
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Implantable Drug Delivery Market, By Product Types (Implantable Bio-Absorbable Stents, Implantable Contraceptive Drug Delivery Devices, Implantable Intraocular Drug Delivery Devices, Implantable Coronary Drug Eluting Stents, Implantable Brachytherapy Seeds and Implantable Drug Infusion Pumps), Technology (Biodegradable Implantable Drug Delivery Device Technology and Non-Biodegradable Implantable Drug Delivery Device Technology), Application (Cardiovascular, Birth Control and Contraception, Ophthalmology, Oncology and Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa) Industry Trends and Forecast to 2029

Implantable Drug Delivery Market Market Analysis and Insights of Implantable Drug Delivery

Implantable drug delivery market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses the market to grow at a CAGR of 8.1% in the above-mentioned forecast period.

Implantable drug delivery market deals with the sales and purchase of implantable drug delivery devices that. These devices are the devices that basically consist of a drug reservoir that is surrounded by a drug polymer mixture. They are generally inserted into the desired area of the body and then the drug is released at a pre-determined rate as the polymer degrades.

The surging demand for minimally invasive medical techniques and the growing prevalence of chronic diseases and other medical threats are the significant factors responsible for driving the growth of the implantable drug delivery market. Additionally, the increase in government funding, the rising awareness amongst people regarding implantable drug delivery devices, increasing demand for contraceptives along with the rising healthcare costs also heighten the overall growth of the market. However, the possibility of implanted device failures and lack of adequate reimbursement in developed economies obstruct the market’s growth. The high cost of devices also impedes overall market’s growth.

The various recent advancements and innovations in medication administration techniques and increasing popularity of microscale implantable devices are expected to generate profitable opportunities for the market. On the other hand, the stringent government regulations and a lack of awareness about infectious disease have the potential to challenge for the market’s growth.

This implantable drug delivery market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on Data Bridge Market Research implantable drug delivery market contact us for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Implantable Drug Delivery Market Scope and Market Size

Implantable drug delivery market is segmented on the basis of product types, technology and application. The growth amongst these segments will help you analyze meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

  • On the basis of product types, the implantable drug delivery market is segmented into implantable bio-absorbable stents, implantable contraceptive drug delivery devices, implantable intraocular drug delivery devices, implantable coronary drug eluting stents, implantable brachytherapy seeds and implantable drug infusion pumps.
  • On the basis of technology, the implantable drug delivery market is segmented into biodegradable implantable drug delivery device technology and non-biodegradable implantable drug delivery device technology.
  • On the basis of application, the implantable drug delivery market is segmented into cardiovascular, birth control and contraception, ophthalmology, oncology and others.

Implantable Drug Delivery Market Country Level Analysis

Implantable drug delivery market is analyzed and market size insights and trends are provided by product types, technology and application as referenced above.

The countries covered in the implantable drug delivery market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the market due to rise in population, growing disease burden and high technology with the updated system is going to create a lot of dominating factors in the market. Asia-Pacific is expected to show a rapid and lucrative growth rate in the forecast period owing to the increasing incidence of diabetes and other chronic diseases, backed by poor lifestyle.

The country section of the implantable drug delivery market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

Implantable drug delivery market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment’s, installed base of different kind of products for implantable drug delivery market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the implantable drug delivery market. The data is available for historic period 2010 to 2020.

Competitive Landscape and Implantable Drug Delivery Market Share Analysis

Implantable drug delivery market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to implantable drug delivery market.

Some of the major players operating in the implantable drug delivery market report are Boston Scientific Corporation, Medtronic, Merck & Co., Inc., Allergan, Bausch & Lomb Pvt Ltd., ANTLIA SA, Elekta AB (publ), Bausch Health Companies Inc., Genentech, Inc., Theragenics, Caesarea Medical Electronics, Halyard Health., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., ZynoMed.com, PHARMIWEB, Kinamed® Incorporated, Stryker , Varian Medical Systems, Inc., Bayer AG,  Arrow International, Inc., Eckert & Ziegler, Elekta AB (publ), and Abbott among others.


SKU-

Why Choose Us


Frequently Asked Questions